NI
PFE icon

Natural Investments’s Pfizer PFE Stock Holding History

Natural Investments’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$449K Buy
18,680
+10,084
+117% +$264K 0.1% 173
2026
Q1 		$241K Sell
8,596
-249
-3% -$6.63K 0.06% 245
2025
Q4 		$220K Buy
+8,845
New +$223K 0.05% 264
2025
Q2 		– Sell
-19,491
Closed -$493K – 268
2025
Q1 		$493K Sell
19,491
-661
-3% -$17.3K 0.14% 136
2024
Q4 		$534K Buy
+20,152
New +$547K 0.15% 135

Other funds holding PFE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Mitsubishi UFJ Asset Management
Mitsubishi UFJ Asset Management Tokyo, Japan $180B AUM 37.51% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Natural Investments's PFE Position: Q2 2026 in Review

Natural Investments increased its Pfizer (PFE) stake by 117% in Q2 2026, buying an estimated $264K and bringing the position to 18,680 shares worth $449K. The position accounts for 0.1% of the portfolio, ranked #173.

Natural Investments first reported a position in PFE in Q4 2024 and has held it in 5 quarters since. The position peaked at $534K in Q4 2024. 1,818 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Natural Investments held 18,680 shares of Pfizer worth $449K as of Q2 2026.
  • Natural Investments bought 10,084 Pfizer shares in Q2 2026, an estimated $264K.
  • Pfizer made up 0.1% of Natural Investments's portfolio in Q2 2026, its #173 holding.
  • Natural Investments first reported a position in Pfizer in Q4 2024 and has held it in 5 quarters since.
  • Natural Investments's Pfizer position peaked at $534K in Q4 2024.
  • 1,818 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Natural Investments's 13F filing for Q2 2026, filed 31 Jul 2026.